company background image
DVLA logo

Darya-Varia Laboratoria IDX:DVLA Stock Report

Last Price

Rp1.62k

Market Cap

Rp1.8t

7D

5.2%

1Y

-17.1%

Updated

23 Jun, 2024

Data

Company Financials

PT Darya-Varia Laboratoria Tbk

IDX:DVLA Stock Report

Market Cap: Rp1.8t

DVLA Stock Overview

Engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia.

DVLA fundamental analysis
Snowflake Score
Valuation4/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends3/6

PT Darya-Varia Laboratoria Tbk Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Darya-Varia Laboratoria
Historical stock prices
Current Share PriceRp1,620.00
52 Week HighRp2,110.00
52 Week LowRp1,375.00
Beta-0.088
11 Month Change6.58%
3 Month Change7.28%
1 Year Change-17.14%
33 Year Change-31.36%
5 Year Change-28.00%
Change since IPO90.59%

Recent News & Updates

Recent updates

Shareholder Returns

DVLAID PharmaceuticalsID Market
7D5.2%0.1%2.0%
1Y-17.1%-22.7%1.0%

Return vs Industry: DVLA exceeded the ID Pharmaceuticals industry which returned -22.7% over the past year.

Return vs Market: DVLA underperformed the ID Market which returned 1% over the past year.

Price Volatility

Is DVLA's price volatile compared to industry and market?
DVLA volatility
DVLA Average Weekly Movement4.2%
Pharmaceuticals Industry Average Movement6.2%
Market Average Movement5.8%
10% most volatile stocks in ID Market13.0%
10% least volatile stocks in ID Market2.7%

Stable Share Price: DVLA has not had significant price volatility in the past 3 months.

Volatility Over Time: DVLA's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19761,271n/awww.darya-varia.com

PT Darya-Varia Laboratoria Tbk engages in the manufacture and trading of pharmaceutical products and cosmetics in Indonesia. It operates in four segments: Prescription Drugs, Consumer Health Products, Export and Toll Manufacturing Services, and Services. The company provides prescription products in various areas of cardiology, analgesics, gastro-hepatology, dermamedic, somatic, cough and cold, antibiotic, women healthcare, antiparasit, vitamin and food supplements, anti fungal, plastic surgery, general surgery, burn, trauma wound, aesthetic medicine, somatik, ear healthcare, and central nerve systems.

PT Darya-Varia Laboratoria Tbk Fundamentals Summary

How do Darya-Varia Laboratoria's earnings and revenue compare to its market cap?
DVLA fundamental statistics
Market capRp1.81t
Earnings (TTM)Rp152.91b
Revenue (TTM)Rp1.91t

11.9x

P/E Ratio

0.9x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
DVLA income statement (TTM)
RevenueRp1.91t
Cost of RevenueRp911.44b
Gross ProfitRp998.58b
Other ExpensesRp845.66b
EarningsRp152.91b

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)136.53
Gross Margin52.28%
Net Profit Margin8.01%
Debt/Equity Ratio0%

How did DVLA perform over the long term?

See historical performance and comparison

Dividends

7.5%

Current Dividend Yield

162%

Payout Ratio

Does DVLA pay a reliable dividends?

See DVLA dividend history and benchmarks
When do you need to buy DVLA by to receive an upcoming dividend?
Darya-Varia Laboratoria dividend dates
Ex Dividend DateJun 24 2024
Dividend Pay DateJul 12 2024
Days until Ex dividend0 days
Days until Dividend pay date18 days

Does DVLA pay a reliable dividends?

See DVLA dividend history and benchmarks
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.